India to Kenya: Chlorpheniramine Export Trade Route

The India to Kenya Chlorpheniramine corridor is one of India's established pharmaceutical export routes, with 159 shipments documented worth a combined $934.5K USD. The route is dominated by ZYDUS LIFESCIENCES LIMITED, which alone accounts for roughly 26% of all export value, reflecting the consolidated nature of India's chlorpheniramine manufacturing sector.

Across 35 active suppliers, the average shipment value stands at $5.9K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 71% of all shipments, consistent with chlorpheniramine's non-urgent bulk-order profile.

Shipment activity peaks during April–June, with an average transit time of 20 days port-to-port. The route has recorded an annual growth rate of 25.4%, placing it at rank #6 among India's top chlorpheniramine export destinations globally.

On the import side, key buyers of Indian chlorpheniramine in Kenya include RIPPLE PHARMACEUTICALS, TO THE ORDER OF, GALAXY PHARMACEUTICAL LIMITED and 50 others. RIPPLE PHARMACEUTICALS is the single largest importer with 3 shipments valued at $119.8K USD.

India's chlorpheniramine exports to Kenya are driven primarily by a handful of large-scale manufacturers. ZYDUS LIFESCIENCES LIMITED with 12 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 35 active exporters signals a competitive but concentrated market — buyers in Kenya benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — ZYDUS LIFESCIENCES LIMITED, ANGEL REMEDIES, WESTCOAST PHARMACEUTICAL WORKS LIMITED — together account for 49% of total trade value on this route. The average shipment value of $5.9K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as pharmaceutical products for human use paracetamol 350mg+chlorpheniramine 4mg+dexamethason 0.5mg+vit.c 100mg capsule and cadistin expectorant 100ml chlorpheniramine maleate bp 2mgsodium citrate usp 44mgvasaka syrupammonium chloride 100mg, suggesting that buyers in Kenya tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, RIPPLE PHARMACEUTICALS is the largest importer with 3 shipments worth $119.8K USD — representing 13% of all chlorpheniramine imports from India on this route. A total of 53 buyers are active on this corridor.